Paul Free, MD
Otolaryngology · Fayetteville, GANPI 1962465179
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,717 of the $4,439 with a category attached, or 83.7%. 28 manufacturers reported payments, led by Stryker at 34.6% of the total.
Across 146 payments — averaging $30.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Sanofi$675
- Optinose US, Inc.$302
- Regeneron Healthcare Solutions, Inc.$287
- Aerin Medical Inc.$283
- GSK$250
- plus $1K from 22 others
What the payments were for
- Travel & lodging$62314%
- Food & beverage$3,71784%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 31 | $1,537 |
| Sanofi | 25 | $675 |
| Optinose US, Inc. | 16 | $302 |
| Regeneron Healthcare Solutions, Inc. | 12 | $287 |
| Aerin Medical Inc. | 4 | $283 |
| GSK | 15 | $250 |
| Inspire Medical Systems, Inc. | 5 | $199 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Phathom Pharmaceuticals, Inc. | 3 | $99 |
| Intersect ENT, Inc. | 3 | $84 |
| Jazz Pharmaceuticals Inc. | 4 | $79 |
| Spirair, Inc. | 1 | $78 |
| Kaleo, Inc. | 4 | $66 |
| Lilly USA, LLC | 2 | $50 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $49 |
| Amgen | 2 | $40 |
| AstraZeneca | 2 | $38 |
| Novartis | 2 | $34 |
| Resmed Corp | 2 | $34 |
| Alk-abello, Inc | 2 | $28 |
| Sanofi US Services Inc. | 1 | $26 |
| Medtronic | 1 | $19 |
| Olympus America Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Baudax Bio Inc. | 1 | $15 |
| Merck | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Ambu Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTELLUS - XPRESS ENT DILATION SYSTEM$603
- ENTELLUS - FOCESS SINUSCOPES$153
- FIAGON NAVIGATION UNIT$141
- VIVAER STYLUS$114
- RHINAER STYLUS$114
How this compares
$4,439 in reported general payments places this provider in the 85th percentile of 308 otolaryngology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $48,646 |
| NucalaMepolizumab | 11 | $39,706 |
| Ipratropium Bromide | 317 | $8,285 |
| Azelastine Hcl | 292 | $6,736 |
| Fluticasone Propionate | 369 | $3,897 |
| Epinephrine | 14 | $3,056 |
| Omeprazole | 254 | $1,835 |
| CefuroximeCefuroxime Axetil | 70 | $1,620 |
| Famotidine | 299 | $1,569 |
| Fluocinolone Acetonide Oil | 41 | $1,249 |
| Ofloxacin | 25 | $1,249 |
| Pantoprazole Sodium | 67 | $657 |
| Clindamycin Hcl | 50 | $437 |
| Mupirocin | 50 | $321 |
| Montelukast Sodium | 69 | $276 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala | $250 | $39,70611 claims |
| Hikma Pharmaceuticals USAEpinephrine | $17 | $3,05614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 308 otolaryngology providers in Georgia.
Other otolaryngology in Fayetteville
- Dozier HoodFayetteville$347K
- Young AnFayetteville$5K
- Christopher MelroySavannah$298K
- Karen HoffmannAtlanta$223K
- Jose StolovitzkyAtlanta$81K
- Jonathan LindmanEvans$55K
- Gregory PostmaAugusta$37K
- Oswaldo HenriquezSmyrna$15K
- Donald BrowningLawrenceville$14K
- Robert GadlageDuluth$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.